41 related articles for article (PubMed ID: 38749552)
1. Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
Palmer TJ; Kavanagh K; Cuschieri K; Cameron R; Graham C; Wilson A; Roy K
J Natl Cancer Inst; 2024 Jun; 116(6):857-865. PubMed ID: 38247547
[TBL] [Abstract][Full Text] [Related]
2. High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.
Tanton C; Soldan K; Beddows S; Mercer CH; Waller J; Field N; Clifton S; Copas AJ; Panwar K; Manyenga P; da Silva F; Wellings K; Ison CA; Johnson AM; Sonnenberg P
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):842-53. PubMed ID: 25737331
[TBL] [Abstract][Full Text] [Related]
3. Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer.
Arroyo Mühr LS; Gini A; Yilmaz E; Hassan SS; Lagheden C; Hultin E; Garcia Serrano A; Ure AE; Andersson H; Merino R; Elfström KM; Baussano I; Dillner J
Nat Commun; 2024 May; 15(1):3679. PubMed ID: 38693149
[TBL] [Abstract][Full Text] [Related]
4. HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data.
Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Nicoll S; Robertson C
Br J Cancer; 2016 Mar; 114(5):576-81. PubMed ID: 26794278
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
[TBL] [Abstract][Full Text] [Related]
6. Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia.
Holy O; Machaczka O; Schovankova T; Navratilova D; Zimmermannova J; Klasterecka R; Vevoda J
Front Public Health; 2024; 12():1347800. PubMed ID: 38813429
[TBL] [Abstract][Full Text] [Related]
7. Evidence-Based Storytelling for a Strategic Roadmap to Promote Cancer Prevention via Adolescent HPV Vaccination in Northern New England.
Dugan M; Stein GS; Carney JK; Clifford-Bova S
Crit Rev Eukaryot Gene Expr; 2024; 34(4):69-102. PubMed ID: 38505874
[TBL] [Abstract][Full Text] [Related]
8. Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
Falcaro M; Soldan K; Ndlela B; Sasieni P
BMJ; 2024 May; 385():e077341. PubMed ID: 38749552
[TBL] [Abstract][Full Text] [Related]
9. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK.
Choi S; Ismail A; Pappas-Gogos G; Boussios S
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839570
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain).
Hernandez-Aguado JJ; Sánchez Torres DÁ; Martínez Lamela E; Aguión Gálvez G; Sanz Espinosa E; Pérez Quintanilla A; Martínez-Carrillo DA; Ramírez Mena M; Coronado Martín PJ; Zapardiel I; de la Fuente-Valero J
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335019
[TBL] [Abstract][Full Text] [Related]
11. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
Falcaro M; Castañon A; Ndlela B; Checchi M; Soldan K; Lopez-Bernal J; Elliss-Brookes L; Sasieni P
Lancet; 2021 Dec; 398(10316):2084-2092. PubMed ID: 34741816
[TBL] [Abstract][Full Text] [Related]
12. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
Kjaer SK; Dehlendorff C; Belmonte F; Baandrup L
J Natl Cancer Inst; 2021 Oct; 113(10):1329-1335. PubMed ID: 33876216
[TBL] [Abstract][Full Text] [Related]
13. HPV Vaccination and the Risk of Invasive Cervical Cancer.
Lei J; Ploner A; Elfström KM; Wang J; Roth A; Fang F; Sundström K; Dillner J; Sparén P
N Engl J Med; 2020 Oct; 383(14):1340-1348. PubMed ID: 32997908
[TBL] [Abstract][Full Text] [Related]
14. Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program.
Racey CS; Albert A; Donken R; Smith L; Spinelli JJ; Pedersen H; de Bruin P; Masaro C; Mitchell-Foster S; Sadarangani M; Dawar M; Krajden M; Naus M; van Niekerk D; Ogilvie G
J Infect Dis; 2020 Jan; 221(1):81-90. PubMed ID: 31504649
[TBL] [Abstract][Full Text] [Related]
15. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
16. Data Resource Profile: National Cancer Registration Dataset in England.
Henson KE; Elliss-Brookes L; Coupland VH; Payne E; Vernon S; Rous B; Rashbass J
Int J Epidemiol; 2020 Feb; 49(1):16-16h. PubMed ID: 31120104
[No Abstract] [Full Text] [Related]
17. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.
Palmer T; Wallace L; Pollock KG; Cuschieri K; Robertson C; Kavanagh K; Cruickshank M
BMJ; 2019 Apr; 365():l1161. PubMed ID: 30944092
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
Mesher D; Panwar K; Thomas SL; Edmundson C; Choi YH; Beddows S; Soldan K
J Infect Dis; 2018 Aug; 218(6):911-921. PubMed ID: 29917082
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
